Bank of Nova Scotia Boosts Position in Avantor, Inc. (NYSE:AVTR)

Bank of Nova Scotia grew its holdings in shares of Avantor, Inc. (NYSE:AVTRFree Report) by 103.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 32,575 shares of the company’s stock after buying an additional 16,551 shares during the period. Bank of Nova Scotia’s holdings in Avantor were worth $744,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in AVTR. Norges Bank purchased a new stake in Avantor in the fourth quarter worth $156,455,000. Invesco Ltd. grew its stake in Avantor by 56.5% in the third quarter. Invesco Ltd. now owns 6,591,898 shares of the company’s stock worth $138,957,000 after purchasing an additional 2,381,154 shares during the period. Westfield Capital Management Co. LP grew its stake in Avantor by 27.6% in the fourth quarter. Westfield Capital Management Co. LP now owns 5,418,922 shares of the company’s stock worth $123,714,000 after purchasing an additional 1,171,976 shares during the period. Public Sector Pension Investment Board grew its stake in Avantor by 65.6% in the third quarter. Public Sector Pension Investment Board now owns 2,538,995 shares of the company’s stock worth $53,522,000 after purchasing an additional 1,005,480 shares during the period. Finally, abrdn plc grew its stake in Avantor by 777.4% in the fourth quarter. abrdn plc now owns 951,775 shares of the company’s stock worth $21,729,000 after purchasing an additional 843,298 shares during the period. 95.08% of the stock is owned by hedge funds and other institutional investors.

Avantor Stock Down 0.2 %

AVTR stock opened at $24.01 on Friday. Avantor, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $26.16. The business’s 50-day moving average is $24.67 and its two-hundred day moving average is $23.66. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.05 and a current ratio of 1.61. The company has a market cap of $16.31 billion, a price-to-earnings ratio of 61.56, a P/E/G ratio of 2.46 and a beta of 1.35.

Avantor (NYSE:AVTRGet Free Report) last posted its earnings results on Friday, April 26th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.02. Avantor had a return on equity of 13.01% and a net margin of 3.79%. The company had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the company earned $0.29 earnings per share. Avantor’s revenue was down 5.6% on a year-over-year basis. As a group, analysts forecast that Avantor, Inc. will post 1.01 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on AVTR. Royal Bank of Canada upped their price target on Avantor from $28.00 to $29.00 and gave the stock an “outperform” rating in a research note on Thursday, February 15th. Deutsche Bank Aktiengesellschaft increased their target price on Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a research note on Thursday, April 18th. Barclays increased their target price on Avantor from $27.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 10th. JPMorgan Chase & Co. increased their target price on Avantor from $26.00 to $29.00 and gave the stock an “overweight” rating in a research note on Thursday, February 15th. Finally, Citigroup increased their target price on Avantor from $24.00 to $30.00 and gave the stock a “buy” rating in a research note on Thursday, February 15th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $26.71.

Get Our Latest Stock Report on Avantor

Avantor Company Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Recommended Stories

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.